1k Views
Japan Pharma - Top Picks
While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP) is a contrarian call in anticipation of value...
771 Views
Smartkarma’s Week that Was in JP/KR: King Street Vs. Toshiba, Korea's Donki, and SKT Split
Below is the list of the Japan/Korea related posts put on the Smartkarma platform last week. It was a holiday week for both Japan and Korea. So, we...
510 Views
Symbio Pharmaceuticals (4582 JP): 1H FY12/25 flash update
Sales dropped 49.7% YoY to JPY647mn, with a gross profit margin of 76.3%, down 1.3pp YoY. Operating loss reached JPY2.2bn, recurring loss...
194 Views
Symbio Pharmaceuticals (4582 JP): Q1 FY12/25 flash update
Sales dropped 55.8% YoY to JPY264mn due to generic competition and inventory adjustments ahead of drug price revision. SG&A expenses rose 7.3%...
235 Views